Stay updated with breaking news from Nasdaq Repl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replimune Group (NASDAQ:REPL – Free Report) had its price target reduced by HC Wainwright from $51.00 to $50.00 in a report published on Monday, MarketBeat.com reports. They currently have a buy rating on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]
HC Wainwright reiterated their buy rating on shares of Replimune Group (NASDAQ:REPL – Free Report) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $51.00 target price on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]
Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.75) EPS for the quarter, topping analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period in the prior year, the firm earned ($0.78) earnings per share. Replimune Group Stock Up 2.8 % REPL stock […]
Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period last year, the business earned ($0.78) earnings per share. Replimune Group Price Performance NASDAQ REPL traded up $0.54 during […]
Emerald Advisers LLC cut its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 963,041 shares of the company’s stock after selling 223,000 shares during the period. Emerald Advisers LLC […]